Global Research Antibodies and Reagents Market, By Product (Reagents, Antibodies), Technology (Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry, Immunofluorescence, Immunoprecipitation, Other Technologies), Application (Proteomics, Drug Development, Genomics), End User (Pharmaceutical & Biotechnologies Industries, Academic & Research Institutions, Contract Research Organizations), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
The research antibodies and reagents market is expected to witness market growth at a rate of 6.15% in the forecast period of 2021 to 2028. Data Bridge Market Research report on research antibodies and reagents market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in investment in life sciences industry is escalating the growth of research antibodies and reagents market.
Research antibodies and reagents are generally utilized for the detection of an unconjugated primary antibody which is further used to target antigen. These products assist in detecting, measuring and purifying proteins or biomolecules in various applications such as flow cytometry, ELISA and western blotting or immunohistochemistry among others.
The rise in demand for high-quality antibodies for research reproducibility acts as one of the major factors driving the growth of research antibodies and reagents market. The growth in proteomics and genomics research and increase in research and development activities to enhance the overall course of diagnosis and treatment accelerate the research antibodies and reagents market growth. The growth in industry-academia collaboration and rising stem cell and neurobiology research field further influences the research antibodies and reagents market. Additionally, rise in funds by profit and non-profit organizations for research projects, increasing focus on biomarker discovery, government support and growing interest in outsourcing positively affect the research antibodies and reagents market. Furthermore, increase in demand for personalized medicine and protein therapeutics and emerging markets extend profitable opportunities to the research antibodies and reagents market players in the forecast period of 2021 to 2028.
On the other hand, cost and time-intensive antibody development processes and pricing pressure over prominent players are the factors expected to obstruct the research antibodies and reagents market growth. The rise in quality concerns and a lack of reproducible results are projected to challenge the research antibodies and reagents market in the forecast period of 2021-2028.
This research antibodies and reagents market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on research antibodies and reagents market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Research Antibodies and Reagents Market Scope and Market Size
The research antibodies and reagents market is segmented on the basis of product, technology, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, the research antibodies and reagents market is segmented into reagents and antibodies. Reagents are further segmented into media & sera, stains & dyes, fixatives, buffers, solvents, enzymes, probes and other reagents. Antibodies are further segmented on the basis of type, form, source and research area. Type is sub-segmented into primary antibodies and secondary antibodies. Form is sub-segmented into monoclonal, polyclonal and recombinant. Source is sub-segmented into mice, rabbits and other sources. Research area is sub-segmented into oncology, infectious diseases, immunology, neurobiology, stem cells and other research areas.
- On the basis of technology, the research antibodies and reagents market is segmented into western blotting, flow cytometry, enzyme-linked immunosorbent assay (ELISA), immunohistochemistry, immunofluorescence, immunoprecipitation and other technologies.
- On the basis of application, the research antibodies and reagents market is segmented into proteomics, drug development and genomics.
- On the basis of end user, the research antibodies and reagents market is segmented into pharmaceutical & biotechnologies industries, academic & research institutions and contract research organizations.
Global Research Antibodies and Reagents Market Country Level Analysis
The research antibodies and reagents market is analyzed and market size insights and trends are provided by country, product, technology, application and end user as referenced above.
The countries covered in the research antibodies and reagents market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the research antibodies and reagents market because of rise in the investments for the development of structure-based drug designs, emphasis on research projects involving proteins, associated biomolecules and genes and increase in the research and development activities in genomics and proteomics sector.
The country section of the research antibodies and reagents market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The research antibodies and reagents market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for research antibodies and reagents market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the research antibodies and reagents market. The data is available for historic period 2011-2019.
Competitive Landscape and Research Antibodies and Reagents Market Share Analysis
The research antibodies and reagents market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to research antibodies and reagents market.
The major players covered in the research antibodies and reagents market report are Thermo Fisher Scientific, Inc., QIAGEN, Abcam plc, Abbott, Bio-Rad Laboratories, Inc., GenScript, Cell Signaling Technology, Inc., Luminex Corporation, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, Danaher Corporation, PerkinElmer, Inc., Lonza, BioLegend, Inc., GE Healthcare, BD, Merck & Co., Inc., Amgen Inc., Sanofi, Rockland Immunochemicals, Inc., Johnson & Johnson Private Limited, Eli Lilly and Company, GenScript, Bio-Techne, Lonza, eva Pharmaceutical Industries Ltd., Santa Cruz Biotechnology, Inc., BioLegend, Inc., Abcam plc., ell Signaling Technology, Inc. among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.